Mitochondria are signaling hubs in cellular physiology that play a role in inflammatory diseases. We found that partial inhibition of the mitochondrial ATP synthase in the intestine of transgenic mice triggers an anti-inflammatory response through NFkB activation mediated by mitochondrial mtROS. This shielding phenotype is revealed when mice are challenged by DSS-induced colitis, which, in control animals, triggers inflammation, recruitment of M1 pro-inflammatory macrophages, and the activation of the pro-oncogenic STAT3 and Akt/mTOR pathways. In contrast, transgenic mice can polarize macrophages to the M2 anti-inflammatory phenotype. Using the mitochondria-targeted antioxidant MitoQ to quench mtROS in vivo, we observe decreased NFkB activation, preventing its cellular protective effects. These findings stress the relevance of mitochondrial signaling to the innate immune system and emphasize the potential role of the ATP synthase as a therapeutic target in inflammatory and other related diseases.
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In Brief
Formentini et al. demonstrate in vivo how the mitochondrial production of ROS in the intestinal epithelium leads to NFkB activation and the protection from inflammation through the recruitment of M2-macrophages, linking mitochondrial activity to the innate immune response of the tissue microenvironment.
INTRODUCTION implicated in inflammatory pathologies such as type 2 diabetes, Crohn's disease, and colon cancer (Galluzzi et al., 2012; Naik and Dixit, 2011; Weinberg et al., 2015) . Inflammatory diseases are often characterized by excessive ROS production (Myant et al., 2013) . Mitochondrial ROS (mtROS) have been suggested to act as signal-transducing molecules that trigger inflammation by driving pro-inflammatory cytokine production (Naik and Dixit, 2011) . Indeed, mtROS and other metabolites derived from mitochondrial activity are critical elements for innate and adaptive immune responses (Colegio et al., 2014; O'Neill, 2014; Osborn and Olefsky, 2012; Weinberg et al., 2015; West et al., 2015) .
The mitochondrial H + -ATP synthase is the rotatory engine of the inner mitochondrial membrane that utilizes the proton electrochemical potential generated by the respiratory chain for the synthesis of ATP (Boyer, 1997) . The activity of the H + -ATP synthase is regulated by its physiological inhibitor, the ATPase Inhibitory Factor 1 (IF1). IF1 is known to block rotatory catalysis of the enzyme when mitochondria become depolarized (Gledhill et al., 2007) . The interaction and inhibitory activity of IF1 on the ATP synthase is prevented by phosphorylation of S39 in IF1 by the action of a mitochondrial cyclic AMP (cAMP)-dependent protein kinase A (PKA) (García-Bermú dez et al., 2015) . The overexpression of IF1, both in cell lines (Formentini et al., 2012; Sá nchez-Aragó et al., 2013; Sá nchez-Cenizo et al., 2010) and in hepatocytes (Santacatterina et al., 2016) and neurons (Formentini et al., 2014) of transgenic mice in vivo, also triggers the inhibition of the synthase by the overloading of the cells with the inhibitor. The inhibition of the ATP synthase by IF1 results in a mild ROS production that acts as a retrograde signal to the nucleus for the activation of different survival pathways (Formentini et al., 2012 (Formentini et al., , 2014 Santacatterina et al., 2016) . The availability of conditional transgenic mice that express human IF1 (hIF1) in a tissue-restricted way (Formentini et al., 2014; Santacatterina et al., 2016) provided the opportunity to test in vivo the relevance of the inhibition of the ATP synthase in inflammation and the immune response.
Herein, we have generated a mouse model expressing hIF1 in the intestinal epithelium to assess the physiological role of the ATP synthase in inflammation. The expression of hIF1 inhibits the activity of oxidative phosphorylation (OXPHOS), mediates the shift of colonocytes to an enhanced glycolysis, and prompts the stimulation of innate immunity through the activation of the AMPK (5 0 AMP-activated protein kinase) pathway and the mtROS-mediated induction of nuclear factor kB (NFkB) signaling. This metabolic reprogramming affords protection against dextran sodium sulfate (DSS)-induced intestinal inflammation and is associated with the recruitment and polarization of intestinal macrophages to the M2 anti-inflammatory phenotype, a reduction in the production of pro-inflammatory cytokines, and a diminished tissue activation of mTOR (mammalian target of rapamycin) signaling. Overall, our findings provide in vivo evidence highlighting the H + -ATP synthase as a target to prevent inflammation.
RESULTS
The Double-Transgenic I/T Mice Express hIF1 in the Intestine To assess the in vivo role of IF1 in the intestinal epithelium, a transgenic Tet-On mouse model was developed. The endogenous expression of IF1 in mice intestine is variable ( Figure 1A ), being high in cecum, intermediate in colon, and negligible in ileum (Figure 1A) . Double-transgenic mice (specifically, I/T mice) expressing hIF1 were obtained by breeding mice containing the human Tet-IF1-47 transgene (I) with mice expressing the intestine-specific Villin-rtTA2-M2 transactivator (T) (Roth et al., 2009) . Western blotting ( Figure 1B ) and immunohistochemistry ( Figure 1C ) with a human-specific anti-IF1 antibody confirmed the expression of hIF1 in colon in response to the administration of doxycycline. Expression of hIF1 promoted a significant reduction in the ATPase activity ( Figure 1D ) but had no effect on the expression of several OXPHOS proteins ( Figure 1E ), with the exception of an increase in SDHB of complex II ( Figure 1E ). Interestingly, the expression of hIF1 in the intestine did not affect the activity of complex IV of the respiratory chain ( Figure 1F ). Consistent with hIF1 exerting a milder inhibition of the ATP synthase than H49K in vivo, we noted that I/T mice showed no relevant differences in the content of ATP in the intestine when compared to controls ( Figure 1G ). Likewise, none of the stress kinases induced by restraining the activity of the ATP synthase with H49K in liver and in brain (AMPK, p38 MAPK [mitogen-activated protein kinase], and Akt) (Formentini et al., 2014; Santacatterina et al., 2016) were affected by the expression of hIF1 in the intestine ( Figure 1H ). 
Metabolic Preconditioning of I/T Mice
In any case, the IF1-mediated inhibition of the H + -ATP synthase in vivo ( Figure 1D ) was able to induce metabolic reprogramming of the intestine to an enhanced glycolysis, as revealed by the increased expression of the glycolytic proteins LDH-A and GAPDH ( Figure 2A ) and data obtained in isolated primary cultures of colonic crypts ( Figures 2B-2D) . Indeed, and consistent with hIF1 inhibiting the ATP synthase in vivo, colonocytes derived from I/T mice ( Figure 2B ) presented a reduction in basal and oligomycin-sensitive respiration when compared to controls (Figure 2C) , in the absence of any effect on maximal respiration (Figure 2C) . Accordingly, I/T colonocytes presented an enhanced glycolysis ( Figure 2D ) that mimicked the effect of the addition of oligomycin ( Figure 2D ).
The inhibition of the H + -ATP synthase by IF1 is known to promote mtROS signaling-both in vivo (Formentini et al., 2014; Santacatterina et al., 2016) and in cells in culture (Formentini et al., 2012 ; Sá nchez-Aragó et al., 2013)-and the subsequent preferential carbonylation of proteins in mitochondria (Figure S1A) . Consistently, I/T mice presented enhanced carbonylation of intestinal proteins when compared to littermate controls ( Figure 2E ). While this is consistent with the generation of mtROS in I/T mice, any such changes were mild, because they did not modify the cellular GSH/GSSG ratio ( Figure 2F ) and did not activate the expression of SOD2 and catalase ( Figure 2E ). Consistently, non-significant differences in steady-state levels of mitochondrial hydrogen peroxide were observed in the colons of I/T mice using the exomarker approach (Logan et al., 2014) ( Figure 2G ). However, activation of the canonical NFkB pathway was shown as the phosphorylation-dependent degradation of its inhibitor IkBa ( Figure 2E ) (Formentini et al., 2012) . Consistent with the activation of the NFkB pathway in the colons of I/T mice, we observed an increase in plasma of interleukin (IL)-6 when compared to controls ( Figure 2H ). However, we also noted that I/T mice showed significantly lower plasma levels of other pro-inflammatory cytokines, such as IL-1a, IL-1b and G-CSF In (A-G), histograms indicate the mean ± SEM of five mice per group assayed in duplicate. *p < 0.05, when compared to control by Student's t test. See also Figure S1A and Table S1 .
(granulocyte colony-stimulating factor) ( Figure 2H ), concurrently with the enhanced plasma expression of the anti-inflammatory cytokine IL-10 ( Figure 2H ). Expression analysis of markers of immune cell populations, cytokines, and other immune-regulatory and NFkB target genes in the colons of control and I/T mice supported the anti-inflammatory phenotype of I/T mice (Table S1) , confirming the enhanced expression of IL-10 and reduction of the pro-inflammatory IL-1b, IL-12, IL-17, and tumor necrosis factor a (TNF-a) (Table S1 ), thus suggesting that the activation of the NFkB pathway by changes in mitochondrial activity could act as an anti-inflammatory signal in the intestine.
Anti-inflammatory Phenotype of I/T Mice
To investigate this possibility, we followed a standard protocol of DSS-induced colitis (Wirtz et al., 2007) . Administration of DSS to the mice induced extensive oxidative damage, as revealed by the nitrosylation and malondialdehyde modification of colon proteins (Figures S1B and S1C). Remarkably, colon extracts of I/T mice experienced less overall oxidative damage than those of controls (Figures S1B and S1C). Consistently, the expression of the transgene significantly reduced the loss in body weight induced by DSS treatment ( Figure 3A) , partially preventing the inflammation-dependent intestinal bleeding (Figure 3B) and the reduction in colon length ( Figure 3C ) when compared to controls.
The histological change score, as assessed in H&E-stained sections (Wirtz et al., 2007) (Figure 3D ), revealed a significant reduction in I/T mice, indicating that the IF1-mediated inhibition of the ATP synthase confers protection to the colonic epithelium from DSS-induced damage. Accordingly, the estimation of cell death by TUNEL or activated caspase-3 was significantly augmented after 10 days of DSS treatment in control when compared to I/T mice ( Figure 3D ). These findings suggest that preconditioning afforded by the overexpression of hIF1 in the intestine provides protection against induced colitis. In agreement with previous findings regarding preconditioning in the liver (Santacatterina et al., 2016), we observed a significant induction of Nrf-2 in the colons of I/T mice after DSS administration ( Figure S1D ).
Signaling the Anti-inflammatory Phenotype
The administration of DSS promoted a stress response in the colons of control and I/T mice, as revealed by the induction of the stress kinases TRIB3 and Akt ( Figure 4A ). However, this response was less pronounced in mice overexpressing hIF1 ( Figure 4A ). Interestingly, I/T mice, but not control mice, activated the metabolic sensor AMPK ( Figure 4A ). The activation of Akt in the absence of AMPK activation is known to activate the mTOR pathway, contributing to colon inflammation and cancer progression (Francipane and Lagasse, 2014) . Consistently, the colons of I/T mice showed, when compared to controls, a lower activation of the mTOR pathway in response to DSS treatment, as revealed by the lower phosphorylation of mTOR, p70S6K, and 4EBP1 ( Figure 4A ) and the concurrent enhanced phosphorylation of raptor and eIF4E proteins ( Figure 4A ). An increase in the expression of the anti-apoptotic Bcl-xL protein in colons of I/T mice was also observed, suggesting that it might contribute to the DSS-resistant phenotype of these animals ( Figure 4A ). However, no relevant changes in the expression of other anti- apoptotic (Mcl-1 and Bcl-2) and autophagy (p62) markers were observed ( Figure 4A ). In agreement with the promotion of an anti-inflammatory phenotype in the colons of I/T mice, despite the NFkB activation observed in these animals ( Figure 4B ), we observed a lesser activation of the pro-inflammatory STAT3 ( Figure 4B) , and of the pro-angiogenic and pro-invasive CD31 and CD14 markers, when compared to controls ( Figure 4B ). Additional markers that emphasize the cell-protective role afforded by the activation NFkB are the maintenance of the expression of the mitochondrial mitofusin 2, OPA1, and VDAC in the colons of I/T mice ( Figure S2 ), suggesting the preservation of mitochondrial integrity in response to the inflammatory stress.
Priming Innate Immunity in I/T Mice
Macrophages are essential components of innate immunity and play key roles in inflammation and disease (Osborn and Olefsky, 2012; Pollard, 2009 ). Hence, we investigated the inflammatory response and potential polarization of macrophages in DSStreated animals ( Figures 5A and S3 ). Immunofluorescence analysis of colon tissue slices from I/T and control mice highlighted a significant infiltration of macrophages after DSS treatment in both phenotypes (F4/80+ staining in Figures 5A and S3) . We did not observe the co-localization of the macrophage F4/80+ marker and Ki67 in the colons of mice after DSS ( Figure S4A ), thus supporting that macrophages in the adult mouse intestine do not proliferate and are replenished by recruitment of blood monocytes (Bain et al., 2014) . In colons of control DSS-treated mice, induced nitric oxide synthase (iNOS) expression was augmented, and the infiltrating macrophages were almost all of the M1 phenotype, as revealed by the co-localization of F4/80+ and iNOS staining ( Figures 5A and S3 ). Infiltrating M2 macrophages (F4/80+ and CD206+ cells) were very low in control DSS-treated mice ( Figures 5A and S3) . Remarkably, the majority of the colon-infiltrating macrophages in DSS-treated I/T mice were of the M2 phenotype, as revealed by the predominant co-localization of F4/80+ and CD206+ staining ( Figures 5A  and S3 ), whereas the number of F4/80+, iNOS+ cells was very low (Figures 5A and S3 ). The lack of F4/80+ and IF1 co-localization ( Figure S4B ) indicated that IF1 is not being expressed in macrophages, excluding potential cell-extrinsic effects. Consistent with these results, blood cytokines in response to DSS treatment revealed enhanced levels of the anti-inflammatory IL-4 and IL-10 ( Figure 5B ) and a significant reduction in pro-inflammatory IL-6 and G-CSF ( Figure 5B ) in I/T mice when compared to controls. Determination of IL-6-and IL-10-positive cells in the colons of control and I/T mice treated with DSS further confirmed the antiinflammatory phenotype of I/T mice ( Figure 5C ). Moreover, canonical discriminant analysis using the expression of 17 relevant immune gene markers (Table S1) , as selected by the algorithm (B220, CCL2, CD206, CD4, EGR1, NFKB1A, BCL2L1, FOS, CTLA4, ARG1, HMGB1, INHBA, NOS2, IL-10, L13, IL-1b, and NFKB1), revealed that the samples from the four experimental groups nicely clustered into four significantly different groups (p = 0.005; Figure 6A ).
In line with the anti-inflammatory phenotype of the colons of I/T mice, we observed that CD4+ T cells were most significantly recruited upon treatment with DSS in the colons of I/T mice ( Figure 6B) . Interestingly, the recruitment of CD4+/FOXP3+ cells (Tregs), those that restrain inflammatory responses, was also significantly augmented in the inflamed colons of I/T mice when compared to those of controls ( Figure 6C ). Overall, the findings support that the IF1-mediated inhibition of the mitochondrial H + -ATP synthase in the intestine induces a state of immune preconditioning favoring an anti-inflammatory phenotype of the tissue by recruiting M2 macrophages and Treg cells.
Quenching mtROS Blocks the Acquisition of the M2 Antiinflammatory Phenotype
One potential link between the IF1-mediated decreased colon inflammation in I/T mice is an elevation in mtROS production. To investigate this in vivo, we administered the mitochondria-targeted antioxidant MitoQ to the mice orally as a MitoQ-b-cyclodextrin adduct (Dashdorj et al., 2013) . It should be noted that the basal carbonylation of cellular proteins observed in colon extracts was significantly reduced after 10 days of MitoQ administration both in control and in I/T mice ( Figure 7A ). In line with the finding that MitoQ decreased oxidative stress, MitoQ administration also inhibited the activation of the NFkB pathway in colon extracts of I/T mice ( Figure 7B ) and abrogated the differences in colon length between control and I/T mice after DSS-induced colitis ( Figure 7C) . Likewise, histological analysis of the colon after DSS administration and MitoQ treatment revealed no differences between control and IF1-expressing mice ( Figure 7D ), thus stressing the relevance of mtROS in promoting the phenotypic differences observed. Likewise, the administration of mesalazine, an inhibitor of the NFkB pathway in inflamed intestinal mucosa (Bantel et al., 2000) , prevented the phosphorylation of IkBa ( Figure 7B ) and essentially reproduced the effect of MitoQ treatment in colon length ( Figure 7C ) and on the histological change scores ( Figure 7D ). These findings further suggest that Table S1 ). Canonical discriminant analysis using 17 of the genes selected by the algorithm revealed that the samples from control (CL) (1, blue), I/T (2, green), CL + DSS (3, red), and I/T + DSS (4, purple) clustered into four different groups. (B and C) Immunofluorescence microscopy of T cells (CD4+) (B) and Tregs (CD4+/FOXP3+) (C) in colons from control (CL) and I/T mice treated or not treated with 2% DSS during 10 days. Colon slices were stained with anti-CD4 (green), anti-FOXP3 (red), and DAPI (nuclei, blue). Scale bars, 80 mm in (B) and 50 mm in (C); scale bar in inset, 10 mm. Histograms show the number of positive cells per field in 12 colon slices per condition. *p < 0.001, when compared to CL+DSS by Student's t test. See also Table S1 . the metabolic preconditioning afforded by inhibition of the ATP synthase involves the production of mild-intensity mtROS, which favors an anti-inflammatory phenotype that is effective when the tissue is subsequently challenged with a stressing insult that involves a major production of ROS. In agreement with the aforementioned findings, the IF1-induced mediated polarization of colon macrophages to the M2 phenotype was partially reverted to the M1 phenotype by MitoQ treatment, as revealed by an enhanced iNOS+ staining in the colons of I/T mice ( Figure 7E ), highlighting mtROS and the NFkB pathway as key mediators in the anti-inflammatory phenotype.
DISCUSSION
Herein, we demonstrate that the expression of hIF1 in the colons of transgenic mice partially inhibits the mitochondrial ATP synthase and promotes the metabolic rewiring of the tissue to an enhanced glycolytic phenotype. Inhibition of the ATP synthase also guides a tissue homeostatic response through the activation of the NFkB pathway by generating the concurrent production of mtROS. We show that the response to acute DSSinduced colitis in control mice is highly aggressive, with elevated plasma levels of the pro-inflammatory cytokines IL6 and G-CSF, the activation of STAT3 and Akt/mTOR pathways, and the functional polarization of tissue macrophages to the M1 pro-inflammatory phenotype. In sharp contrast to the expected pro-inflammatory role of the activation of NFkB in the intestine (Karin and Greten, 2005) , the response of transgenic mice to DSSinduced colitis is less aggressive, showing enhanced plasma levels of the anti-inflammatory IL4 and IL10 cytokines, decreases of the pro-inflammatory IL6 cytokine, the activation of AMPK, the polarization of tissue macrophages to the M2 anti-inflammatory phenotype, and the enhanced recruitment of Treg cells that restrain inflammatory responses. In vivo, the mitochondria-targeted antioxidant MitoQ obliterated the activation of NFkB and its cellular protective effects after the induction of colon inflammation, stressing the relevance of mitochondrial signaling in vivo to the innate immune system of the tissue microenvironment. Overall, these findings emphasize the potential role of the mitochondrial ATP synthase as a therapeutic target in inflammatory and other related diseases.
In vitro findings have suggested a role for IF1 as a unidirectional inhibitor of the ATP hydrolase activity of the mitochondrial ATP synthase (Walker, 2013) , especially under conditions of a compromised bioenergetic function of the organelle (Campanella et al., 2008) . However, as recently discussed in detail (Formentini et al., 2014; Santacatterina et al., 2016) , findings in vivo have shown that IF1 overexpression exerts inhibition of both the synthase activity and hydrolase activity of the enzyme (García -Bermú dez et al., 2015) . This contribution, thus, adds an additional in vivo system arguing in the same way.
Consistent with previous findings in cells in culture (Formentini et al., 2012) and in neurons and hepatocytes of the transgenic mice (Formentini et al., 2014; Santacatterina et al., 2016) , we observed that the overexpression of IF1 in the colon leads to the carbonylation of some cellular proteins and promotes the activation of the NFkB pathway. In addition, the IF1-mediated signal can be quenched by MitoQ, a mitochondria-targeted antioxidant. Together, these findings are consistent with an mtROS signal, perhaps produced by reverse electron transfer at complex I due to the elevation of the proton motive force that accompanies inhibition of the ATP synthase (Brand et al., 2004) . However, as this signal is unable to significantly alter the cellular redox state, it is of mild intensity. mtROS can promote the activation of both the canonical and noncanonical NFkB pathways at various levels. We found that the IF1-mediated NFkB activation in the colon in vivo is exerted by the canonical pathway, as revealed by the phosphorylation-dependent degradation of the repressor IkBa, in agreement with previous findings in colon cancer cells (Formentini et al., 2012) . Despite the activation of NFkB, which is a master regulator of the inflammatory response (Karin, 2006) , we noted no relevant phenotypic changes in hIF1-expressing mice when compared to control animals. Phenotypic differences arouse only when I/T mice were challenged with an acute cytotoxic stress. Similar situations have been observed in models of neuronal excitotoxicity and hepatotoxicity using transgenic mice that express the more active IF1-H49K mutant (Formentini et al., 2014; Santacatterina et al., 2016) . Thus, these findings support that restraining the activity of mitochondrial OXPHOS, specifically at the ATP synthase level, affords a state of metabolic preconditioning of the tissue that allows cells to withstand further deleterious insults, i.e., mitohormesis (Chandel, 2015; Shadel and Horvath, 2015; Yun and Finkel, 2014) . Both genetic (Sun et al., 2014) and metabolic inhibition of the ATP synthase (Chin et al., 2014; Fu et al., 2015) have been shown to propitiate life extension in different organisms. Interestingly, and as is shown in this study, common to these situations is the inhibition of the mTOR pathway and the production of mtROS via reverse electron transport, which are known to extend animal lifespan (Chin et al., 2014; Scialò et al., 2016) . Hence, we speculate that the mtROS-mediated activation of the NFkB pathway plays a prominent role in the cellular adaptations that facilitate mitohormesis. As mentioned earlier, NF-kB signaling represents a key mechanism contributing to gut inflammation and colitis, acting as a central mediator of pro-inflammatory cytokine and chemokine production (Karin and Greten, 2005) . To our surprise, but consistent with recent findings that indicate a complex tissue-specific role for the NF-kB pathway in inflammation (Greten et al., 2007; Lawrence et al., 2001; Zhong et al., 2016) , the IF1-mediated activation of this pathway in the colons of I/T mice resulted in an antiinflammatory phenotype. Consistent with our findings, deletion of negative regulators of the NFkB pathway leads to an increased susceptibility to DSS-induced colitis (Garlanda et al., 2004; Lee et al., 2000) . Accordingly, we show that reducing the activation of NFkB by the administration of mesalazine is sufficient to abrogate the IF1 anti-inflammatory effect. The activation of autophagy has been shown to be involved in the anti-inflammatory effect of NFkB (Criollo et al., 2010; Zhong et al., 2016) . However, we found no relevant changes in p62-guided mitophagy, suggesting that the anti-inflammatory effect of NFkB in our model is exerted by a different mechanism. The preconditioned tissue of transgenic mice responded to DSS administration with a lesser activation of the stress kinase TRIB3 and a diminished cell death, consistent with the negative regulation that the kinase exerts on NFkB, sensitizing cells to TNF-and TRAIL (TNF-related apoptosisinducing ligand)-induced apoptosis (Wu et al., 2003) . Moreover, whereas transgenic mice activated the metabolic stress kinase AMPK in response to DSS-induced colitis, control mice activated the pro-inflammatory and pro-oncogenic STAT3 and Akt/mTOR pathways (Buettner et al., 2002; Francipane and Lagasse, 2014) , suggesting that the colons of mice that overexpress hIF1 might be protected from cancer development, compared to control animals. These results might provide a mechanistic explanation to the finding that the overexpression of IF1 in human colon carcinomas is associated with a better patient prognosis (Sá nchez- Aragó et al., 2013) , while its overexpression in other carcinomas provides a marker of poor patient prognosis (García-Bermú dez and Cuezva, 2016) . Interestingly, the colons of I/T mice showed a decreased STAT3 phosphorylation in the context of increased IL6 and IL10. Since both cytokines trigger the phosphorylation of the transcription factor, we suggest that the reduced phosphorylation of STAT3 in the colons of I/T mice might result from the reduced oxidative damage experienced by these animals in response to DSS. In fact, the phosphorylation of STAT3 also depends on the activity of the protein phosphatase Ptp1b, which is known to be inactivated by ROS (Meng et al., 2002) . This suggestion agrees well with the observed higher induction of a potential Nrf-2-guided antioxidant response in the colons of the pre-conditioned I/T mice.
Excessive ROS production causes tissue damage. However, a mild ROS production represents a first line of defense against microbial invasion (West et al., 2011) , and its suppression reduces innate immune responses (Break et al., 2012) . Macrophages are tissue sentinels whose activation is pivotal in restoring tissue integrity and function (Karin and Clevers, 2016) . M1 (classically activated) macrophages produce inflammatory cytokines and nitric oxide and are considered more inflammatory (Murray and Wynn, 2011) . In contrast, M2 (alternatively activated) macrophages are involved in tissue repair and are considered anti-inflammatory (Murray and Wynn, 2011) . M1 and M2 macrophages also differ significantly in the major pathways of energy provision (Mills and O'Neill, 2016) with the adaptations in their mitochondrial respiratory chain playing a relevant role in the antibacterial host defense (Garaude et al., 2016) . The source, site, and intensity of the ROS influence the regulation of macrophage signaling and polarization (see Mills and O'Neill, 2016 , for a recent review). It has been recently shown that the inhibition of the mitochondrial electron transport chain induces metabolic rewiring of macrophages and controls inflammation by remodeling the Krebs cycle (Lampropoulou et al., 2016) . Moreover, other findings also support that lactate, the product of aerobic glycolysis, mediates macrophage polarization from the M1 pro-inflammatory phenotype to the M2 anti-inflammatory phenotype (Colegio et al., 2014) . We observed that quenching mtROS production obliterated the activation of NFkB, abolished the advantageous antiinflammatory phenotype, promoted the increased expression of iNOS, and reduced the recruitment of M2 macrophages or partially suppressed their polarization to the M2 phenotype in the colons of transgenic mice. Since it is unlikely that MitoQ could affect the cell metabolome or the rates of glycolysis imposed by inhibition of the ATP synthase, we suggest that the activation of the NFkB pathway by mtROS in the colons of transgenic mice expressing hIF1 represents the basic mechanism that triggers a higher recruitment and/or polarization of tissue macrophages to the M2 anti-inflammatory phenotype in response to DSS-induced colitis.
Overall, the findings support that the mitochondrial ATP synthase could represent a relevant target to promote macrophage class switching with therapeutic purposes in a number of inflammatory diseases.
EXPERIMENTAL PROCEDURES Transgenic Animals
The pCMV-SPORT6-IF1 plasmid (ATCC) (Sá nchez-Cenizo et al., 2010) containing the human IF1 was PCR amplified, and the PCR product was assembled into the pTRE2hyg vector (Clontech Laboratories) in the BamHI and Notl restriction sites. The TRE2hyg-IF1 plasmid was digested with SexAI/ Drdl (New England Biolabs), and the 2.5-kb DNA fragment of interest was purified using the Elu-Quik DNA Purification Kit (Shleicher & Schuell). Transgenic mice (TRE-IF1-47, I) were obtained by pronuclear microinjection of the construct by the Servicio de Trangenesis of the CNB/CBMSO (UAM), using standard protocols. Integration of the construct was confirmed by PCR (forward, 5 0 -CACAGAGTAGAGAACAACTG-3 0 ; reverse, 5 0 -GTTAGTAGCACAC AGACAAA-3 0 ). The Villin-rtTA2-M2 mice (T), expressing the transactivator rtTA in intestinal epithelium (Roth et al., 2009) were used. The Tet-On double-transgenic (I/T) animals were obtained by breeding I and T mice (Figure S5A ). Animals were maintained on the C57/Bl6 genetic background. To turn on the expression of IF1, 6-month-old double-transgenic mice were administered doxycycline (2 mg/mL) in the drinking water during 15 days (Figure S5B ). The same treatment was applied to littermate controls (genotypes I, T, and wild-type) that do not express human IF1 ( Figure S5B ). Both male and female control and I/T mice were used in the studies. Animal experiments were carried out after approval of the institutional review board (Ethical Committee of the UAM, CEI-52-961) in compliance with animal policies and ethical guidelines of the European Community.
Primary Cultures of Colonocytes
Mature non-dividing epithelial cells forming the colonic epithelium were obtained as previously described (Booth and O'Shea, 2002) . Oxygen consumption rates in isolated colonocytes (500 mg protein) were determined in a Clark-type electrode. TMPD-ascorbate (10 mM) was used as a respiratory substrate in the presence or absence of 0.5 mM ADP, 6 mM oligomycin, 5 mM FCCP, and 1 mM antimycin A.
The rates of lactate production were determined enzymatically, as previously reported (Sá nchez-Cenizo et al., 2010).
Determination of the ATP Synthase Activity
Colonocytes resuspended in respiration buffer containing 1% Triton X-100 were used for the spectrophotometric determination of complex V activity, as previously described (Barrientos et al., 2009 ).
Detection of Inflammatory Cytokines
For the determination of a panel of inflammatory cytokines, the Multi-Analyte ELISArray Kit (QIAGEN) was used.
DSS-Induced Acute Colon Inflammation and Histology
Six-month-old control (n = 18) and I/T (n = 18) doxycycline-treated mice were used ( Figure S5B ). To induce acute intestinal inflammation, 2% DSS was added in the drinking water for 9 days (Wirtz et al., 2007) in the presence or absence of the anti-inflammatory drug mesalazine (75 mg/kg/day) or the mitochondrial scavenger MS-010 (MitoQ with b-cyclodextrin, 500 mM) simultaneously with doxycycline ( Figure S5B ). Determination of weight and examination of inflammation-associated rectal bleeding were conducted every day for 10 days. Mice were sacrificed at day 10, and the colons were recollected. Sections (30 mm thick) were taken in the coronal plane, stained with H&E for the evaluation of the histological score (Wirtz et al., 2007) , and processed for immunohistochemistry or other analysis.
Western Blot and Analysis of Protein Carbonylation
Protein samples from colons or colonocytes were fractionated on SDS-PAGE. Details of the antibodies used in western blots are provided in Supplemental Information. For the determination of protein carbonylation, the Oxyblot Oxidized Protein Detection Kit (Chemicon International) was used. 
Statistical Analysis
Statistical analyses were performed using a two-tailed Student's t test. ANOVAs with post hoc Dunnett's test were used for multiple comparisons to the control, using the SPSS 17.0 software package. The results are indicated as mean ± SEM. A p < 0.05 was considered statistically significant.
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